Studies of the Pathogenesis of Chronic Inflammatory Rheumatic Diseases


About this study

This study is being done to learn more about diseases with chronic and harmful inflammation. This study will look at what causes these diseases;  whether these diseases are inherited (genetic) or acquired (not genetic or inherited); and what are the signs, symptoms, or tests that can be used to predict how a patient will respond to therapy or which therapy may be the best one to use.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:    

  • Presence of an inflammatory, rheumatic, and autoimmune diseases.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Eric Matteson, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer